Nymox Pharm Corp (NYMXF)

$0.07 -0.02 (-22.22%)
Market Cap 8.42M
Revenue (ttm) 0.00
Net Income (ttm) -8.84M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 25,000
Avg Vol 15,906
Day's Range N/A - N/A
Shares Out 93.54M
Stochastic %K 42%
Beta 10.18
Analysts Strong Buy
Price Target N/A

Company Profile

Nymox Pharmaceutical Corporation, a biopharmaceutical company, engages in the research and development of products for the aging population. Its lead drug candidate is Fexapotide Triflutate (NX-1207) for the treatment of benign prostatic hyperplasia and low-grade localized prostate cancer, as well as hepatocellular carcinoma. The company also offers NicAlert, a test for determining smoking status; and TobacAlert, a test for detecting second-hand smoke exposure. In addition, it develops drugs for...

Industry: Biotechnology
Sector: Healthcare
Phone: 800 936 9669
Fax: 514 332 2227
Website: nymox.com
Address:
Bay & Deveaux Streets, 2nd Floor, Nassau, Bahamas
Passeraser
Passeraser Sep. 8 at 8:38 PM
$NYMXF When the company has something to say you will hear it . No consolidatio no bankruptcy . All OK
0 · Reply
usa2018
usa2018 Sep. 4 at 7:28 PM
$NYMXF The Lawsuits by Dr A filed and withdrawn against Restore and Ascella Groups were result of getting news that UK was rejecting the drug. There can be no damages if no approval so he was forced to withdraw by Robinsons attorney's, The Mark didn't want to fund a loser, sure it’s Prejudice, if a MIRACLE APPROVAL happens he can refile. Good luck with that DREAM. Upon that news Robinson seems to have decided Nymox and Dr A are a lost cause and ended funding the charade of Nymx non-performance and might just be funding legal expenses for Liability due to malicious actions Nymx. Dr A is hidden like he’s in Witness Protection, practicing for the future when he squeals to get out of Shareholder Lawsuits. Dr A is hoping it all goes away but the Truth always catches the Con Men. Speaking of Con Men I see Passeraser is back criticizing me. You and your Canadian can't trade in Canada but as always you believe all is well. lease provide evidence as proof and not the usual nonsense.
1 · Reply
usa2018
usa2018 Sep. 4 at 7:19 PM
$NYMXF Time line for Rejected Drug in UK Part 2. Stage 4 – Final Decision • After receiving the CHM recommendation, (MHRA) makes its final decision. • Again, no strict statutory deadline here, but typically a few weeks to a few months. ✅ Overall maximum timeline (worst case, including extensions): • ~1 year to 1 year 3 months from initial notification to final MHRA decision. If you skip the Review Panel and stick to written representations only, it’s usually closer to 6–9 months NYMOX AND Dr A are way off the Timeline of UK.
0 · Reply
usa2018
usa2018 Sep. 4 at 7:18 PM
$NYMXF Time line for Rejected Drug in UK over 2 Posts. Stage 1 – Notification of Provisional Grounds (Schedule 11, para 11) • MHRA/CHM sends notice • 28 days: You must notify the written or oral representations. • Up to 6 months: You must actually submit those representations • Elapsed time so far: ~6 months + 28 days (worst case). Stage 2 – CHM Consideration & Recommendation • After receiving your representations, the CHM reviews • The Regulations don’t set a fixed limit here, but in practice this takes a few months. Stage 3 – Oral Representations & Review Panel (Schedule 5, if requested) If you elect oral representations and request a formal independent review: • 3 months: You must provide the Review Panel with a written summary • Possible extension to 6 months maximum • 60 days: Panel must deliver its report after the hearing • The Licensing Authority must then take that report into account in its final decision. Elapsed time for this stage: 3–6 months + 60 days.
0 · Reply
usa2018
usa2018 Sep. 4 at 7:16 PM
$NYMXF
0 · Reply
usa2018
usa2018 Sep. 4 at 7:16 PM
$NYMXF As always, my Posts are factual and latest research revealed some interesting info. Dr A is just intentionally delaying the Approval Process as usual after being Rejected again. See attached timelines in following Posts by UK authorities. If Dr A is so confident in his applications, why is he delaying the Appeal by requesting repeated extensions that are rejected. His goal is to keep clock running so he looks good and doesn't need to report failure of the Drug. It’s taken 31 years, $100 million, 1 failed trial, 8 applications and 8 rejections to get to this point! This could make the Guinness Book records for the Biggest Loser! Looks like Dr A was attempting to manipulate data to appeal his rejections, like the false data he gave the Dr Roehrborn, to publish his Paper on Nymox in 2020. Dr A has no money. His latest 6 mth extension request was denied by UK, see attached FOI application which shows MHRA are up to date with no backlog in application processing and evaluation
0 · Reply
usa2018
usa2018 Aug. 29 at 4:55 PM
$NYMXF There are zero trades so far today. At 6 cents per share I would think the supporters of Dr A and Nymox would be buying tons of shares. Then I realized people in Canada can’t buy or sell stock in this prize of a company so that really limits the interest in Nymox in a very big way. I’m sure people in Canada that recommended Nymox to their friends now have less friends. LOL That Dr A is sure a slippery one!
0 · Reply
usa2018
usa2018 Aug. 29 at 3:29 PM
$NYMXF Remember this all started due to the Restore Group requesting a Shareholder Meeting and Dr A refusing to schedule one. An Annual Meeting is one that Management should schedule every year voluntarily. The last Annual Meeting Dr A had I believe was in 2020. Dr A most likely doesn’t care about any of the Lawsuits he’s involved in. He has The Mark, Robinson, paying for everything, has a company that is worthless and according to his Doorman in Monaco Dr. A is in hiding with his Russian love connection. As long as Robinson keeps giving Dr A money, he remains in hiding and is safe. Unfortunately, The Mark has to pay Big Money to Dr A’s top priced lawyers while the Restore Group are Lawyers so there is no expense! Believe me there is no end in sight for Nymox and Dr A’s legal battles. Very soon because Dr A is in permanent hiding there will be a request to Serve Legal Papers by way of his Registered Agent, then the fun will really begin.
1 · Reply
usa2018
usa2018 Aug. 28 at 6:00 PM
$NYMXF This PR will make The Mark, aka Mr Robinson, and more importantly his heirs happy. At this point Robinson can not have much money left to support Dr A on his permanent vacation. Maybe by early next week the 8 Jurisdictions that Rejected Nymox will issue a PR that goes like this. Unfortunately we the 8 Jurisdictions were incredibly mismanaged and dishonest the last 9 years during the time Dr A submitted the applications for approval. Dr. A is incredibly professional, knowledgeable, honest and a true visionary. His communication skills, compliance with protocols and procedures are unmet in the industry. His attention to the details and requirements in Drug Development is worthy of a Nobel. Please excuse our mismanagement over the past 9 years which caused inexcusable delays for Nymox and Patients. Effective immediately Nymox’s drug will be approved in all 8 Jurisdictions. Nah! Most of us know that’s not going to happen. Just joking like the Fraud Dr. A does to his Shareholders
0 · Reply
giannobes14
giannobes14 Aug. 27 at 9:04 PM
$NYMXF Ok well hopefully the Langham & Riley stuff is over for now. Would love some real business updates. I plugged timeline for UK into chatGPT and we are actually still in range albeit at the long end but not too uncommon for first time drugs / small companies to have extended this long.
0 · Reply
Latest News on NYMXF
No data available.
Passeraser
Passeraser Sep. 8 at 8:38 PM
$NYMXF When the company has something to say you will hear it . No consolidatio no bankruptcy . All OK
0 · Reply
usa2018
usa2018 Sep. 4 at 7:28 PM
$NYMXF The Lawsuits by Dr A filed and withdrawn against Restore and Ascella Groups were result of getting news that UK was rejecting the drug. There can be no damages if no approval so he was forced to withdraw by Robinsons attorney's, The Mark didn't want to fund a loser, sure it’s Prejudice, if a MIRACLE APPROVAL happens he can refile. Good luck with that DREAM. Upon that news Robinson seems to have decided Nymox and Dr A are a lost cause and ended funding the charade of Nymx non-performance and might just be funding legal expenses for Liability due to malicious actions Nymx. Dr A is hidden like he’s in Witness Protection, practicing for the future when he squeals to get out of Shareholder Lawsuits. Dr A is hoping it all goes away but the Truth always catches the Con Men. Speaking of Con Men I see Passeraser is back criticizing me. You and your Canadian can't trade in Canada but as always you believe all is well. lease provide evidence as proof and not the usual nonsense.
1 · Reply
usa2018
usa2018 Sep. 4 at 7:19 PM
$NYMXF Time line for Rejected Drug in UK Part 2. Stage 4 – Final Decision • After receiving the CHM recommendation, (MHRA) makes its final decision. • Again, no strict statutory deadline here, but typically a few weeks to a few months. ✅ Overall maximum timeline (worst case, including extensions): • ~1 year to 1 year 3 months from initial notification to final MHRA decision. If you skip the Review Panel and stick to written representations only, it’s usually closer to 6–9 months NYMOX AND Dr A are way off the Timeline of UK.
0 · Reply
usa2018
usa2018 Sep. 4 at 7:18 PM
$NYMXF Time line for Rejected Drug in UK over 2 Posts. Stage 1 – Notification of Provisional Grounds (Schedule 11, para 11) • MHRA/CHM sends notice • 28 days: You must notify the written or oral representations. • Up to 6 months: You must actually submit those representations • Elapsed time so far: ~6 months + 28 days (worst case). Stage 2 – CHM Consideration & Recommendation • After receiving your representations, the CHM reviews • The Regulations don’t set a fixed limit here, but in practice this takes a few months. Stage 3 – Oral Representations & Review Panel (Schedule 5, if requested) If you elect oral representations and request a formal independent review: • 3 months: You must provide the Review Panel with a written summary • Possible extension to 6 months maximum • 60 days: Panel must deliver its report after the hearing • The Licensing Authority must then take that report into account in its final decision. Elapsed time for this stage: 3–6 months + 60 days.
0 · Reply
usa2018
usa2018 Sep. 4 at 7:16 PM
$NYMXF
0 · Reply
usa2018
usa2018 Sep. 4 at 7:16 PM
$NYMXF As always, my Posts are factual and latest research revealed some interesting info. Dr A is just intentionally delaying the Approval Process as usual after being Rejected again. See attached timelines in following Posts by UK authorities. If Dr A is so confident in his applications, why is he delaying the Appeal by requesting repeated extensions that are rejected. His goal is to keep clock running so he looks good and doesn't need to report failure of the Drug. It’s taken 31 years, $100 million, 1 failed trial, 8 applications and 8 rejections to get to this point! This could make the Guinness Book records for the Biggest Loser! Looks like Dr A was attempting to manipulate data to appeal his rejections, like the false data he gave the Dr Roehrborn, to publish his Paper on Nymox in 2020. Dr A has no money. His latest 6 mth extension request was denied by UK, see attached FOI application which shows MHRA are up to date with no backlog in application processing and evaluation
0 · Reply
usa2018
usa2018 Aug. 29 at 4:55 PM
$NYMXF There are zero trades so far today. At 6 cents per share I would think the supporters of Dr A and Nymox would be buying tons of shares. Then I realized people in Canada can’t buy or sell stock in this prize of a company so that really limits the interest in Nymox in a very big way. I’m sure people in Canada that recommended Nymox to their friends now have less friends. LOL That Dr A is sure a slippery one!
0 · Reply
usa2018
usa2018 Aug. 29 at 3:29 PM
$NYMXF Remember this all started due to the Restore Group requesting a Shareholder Meeting and Dr A refusing to schedule one. An Annual Meeting is one that Management should schedule every year voluntarily. The last Annual Meeting Dr A had I believe was in 2020. Dr A most likely doesn’t care about any of the Lawsuits he’s involved in. He has The Mark, Robinson, paying for everything, has a company that is worthless and according to his Doorman in Monaco Dr. A is in hiding with his Russian love connection. As long as Robinson keeps giving Dr A money, he remains in hiding and is safe. Unfortunately, The Mark has to pay Big Money to Dr A’s top priced lawyers while the Restore Group are Lawyers so there is no expense! Believe me there is no end in sight for Nymox and Dr A’s legal battles. Very soon because Dr A is in permanent hiding there will be a request to Serve Legal Papers by way of his Registered Agent, then the fun will really begin.
1 · Reply
usa2018
usa2018 Aug. 28 at 6:00 PM
$NYMXF This PR will make The Mark, aka Mr Robinson, and more importantly his heirs happy. At this point Robinson can not have much money left to support Dr A on his permanent vacation. Maybe by early next week the 8 Jurisdictions that Rejected Nymox will issue a PR that goes like this. Unfortunately we the 8 Jurisdictions were incredibly mismanaged and dishonest the last 9 years during the time Dr A submitted the applications for approval. Dr. A is incredibly professional, knowledgeable, honest and a true visionary. His communication skills, compliance with protocols and procedures are unmet in the industry. His attention to the details and requirements in Drug Development is worthy of a Nobel. Please excuse our mismanagement over the past 9 years which caused inexcusable delays for Nymox and Patients. Effective immediately Nymox’s drug will be approved in all 8 Jurisdictions. Nah! Most of us know that’s not going to happen. Just joking like the Fraud Dr. A does to his Shareholders
0 · Reply
giannobes14
giannobes14 Aug. 27 at 9:04 PM
$NYMXF Ok well hopefully the Langham & Riley stuff is over for now. Would love some real business updates. I plugged timeline for UK into chatGPT and we are actually still in range albeit at the long end but not too uncommon for first time drugs / small companies to have extended this long.
0 · Reply
svseeker3000
svseeker3000 Aug. 27 at 8:15 PM
$NYMXF https://www.pacermonitor.com/public/case/57782493/Randall_J_Lanham_v_Computershare_Limited_et_al
0 · Reply
usa2018
usa2018 Aug. 25 at 3:18 PM
$NYMXF ..Obviously Nymox Stock can not currently be traded in Canada so those investors surely must love Dr. A’s management. But there are no trades today on the one or two exchanges that allow trading in Nymox Stock. Is Nymox Stock halted pending the release of great or at least good news?
1 · Reply
IP_Slow
IP_Slow Aug. 24 at 6:30 PM
$NYMXF I assume we will be suing to recover legal expenses. That could leave a mark
1 · Reply
svseeker3000
svseeker3000 Aug. 23 at 1:47 PM
$NYMXF https://www.pacermonitor.com/public/case/57782493/Randall_J_Lanham_v_Computershare_Limited_et_al
1 · Reply
usa2018
usa2018 Aug. 22 at 4:52 PM
$NYMXF looks like some high roller just invested 50 cents and bought 9 shares. Wish I had known, i would have advanced the Buyer 5 cents to make it an even 10 share purchase. hmmm…..maybe it was Big Pharma starting a position with 9 shares in anticipation of a buyout!
1 · Reply
usa2018
usa2018 Aug. 22 at 3:49 PM
$NYMXF I was just searching info on Nymox and found some interesting info. Nymox is still not compliant in Canada so all those people who bought through the Canadian Exchange are unable to trade, sell the stock until Dr. A and Nymox file the necessary filings. Imagine not even being able to get 5 cents per share and close out your position for tax purposes or sell the stock so to use the cash if needed. That's what Dr. A provides the Shareholders, the owners, of Nymox. I'm also fairly sure that Dr. A pledged his stock to the Canadian Authorities due to Dr A not paying his taxes. So why would Dr A be interested in his Shareholders in Canada when he would not be able to benefit by selling his own stock. I'm surprised The Mark, 90 year old Robinson, has not paid Dr A's taxes or maybe he did give Dr A the money for taxes but it went towards his disappearance. Dr. A is just the top Jokester in the Nymox Family of Fraud.
0 · Reply
IP_Slow
IP_Slow Aug. 21 at 7:11 PM
$NYMXF nice volume
1 · Reply
Passeraser
Passeraser Aug. 21 at 2:47 PM
$NYMXF filings are current ! No Consolidation , no Bankruptcy . Submissions still alive !
2 · Reply
svseeker3000
svseeker3000 Aug. 21 at 2:30 PM
$NYMXF https://www.pacermonitor.com/public/case/57782493/Randall_J_Lanham_v_Computershare_Limited_et_al
0 · Reply
svseeker3000
svseeker3000 Aug. 14 at 4:31 PM
$NYMXF https://www.pacermonitor.com/public/case/57830097/Chris_Riley_v_Computershare_Limited_et_al
1 · Reply
usa2018
usa2018 Aug. 13 at 12:57 PM
$NYMXF Nymox Board of Directors, does it still exist? Dr. A treated the Board like his own little club adding and removing Directors like Attorney Doody without any Vote or Authorization from the Owners, The Shareholders. Attorney Doody looks like he has made an exit from Management/Board Positions due to the Fraud of Dr. A. 90 year old Mr. Robinson, well he is a puppet unfortunately and apparently has no family or trusted advisors to protect him from writing checks to Dr. A. Mr. Robinson is lost but Attorney Doody surely knows due to SEC Regulations that Dr A is required to file Quarterly Financials, well we know that’s not happening. Attorney Doody is most likely trying to limit his Liability by keeping a low profile and hoping everybody forgets about him. He will be remembered and I sure hope he is paying his Errors and Omission Insurance Premiums promptly. I sure wish for my own benefit somebody could provide evidence that I’m wrong instead of just criticizing my posts.
1 · Reply
usa2018
usa2018 Aug. 12 at 6:28 PM
$NYMXF I just looked at the price, 5 cents. Looks like Nymox took the final turn and is now headed to the grave yard.
0 · Reply